Loading clinical trials...
Loading clinical trials...
A Randomized, Rater-Blinded Study to Explore the Effect of Mefloquine in Subjects With Progressive Multifocal Leukoencephalopathy (PML)
Conditions
Interventions
mefloquine
Locations
12
United States
Research Site
Chicago, Illinois, United States
Research Site
Baltimore, Maryland, United States
Research Site
Boston, Massachusetts, United States
Research Site
St Louis, Missouri, United States
Research Site
New York, New York, United States
Research Site
São Paulo, Brazil
Start Date
January 1, 2009
Primary Completion Date
November 1, 2010
Completion Date
November 1, 2010
Last Updated
July 31, 2014
NCT04453917
NCT03399981
NCT01132053
NCT04091932
Lead Sponsor
Biogen
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions